|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net Income (Loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Depreciation, depletion and amortization | |||||
| Accretion of asset retirement and environmental obligations | |||||
| Accretion of discount on short-term investments | |||||
| Gain on early extinguishment of debt | |||||
| Loss on disposals of long-lived assets, net | |||||
| Stock-based compensation expense | |||||
| Amortization of debt discount and debt issuance costs | |||||
| Write-downs of inventories | |||||
| Revenue recognized in exchange for debt principal reduction | |||||
| Deferred income taxes | |||||
| Other | |||||
| Decrease (increase) in operating assets: | |||||
| Trade accounts receivable (including related party) | |||||
| Income taxes receivable | |||||
| Other receivables | |||||
| Inventories | |||||
| Prepaid expenses, other current and non-current assets | |||||
| Increase (decrease) in operating liabilities: | |||||
| Accounts payable and accrued liabilities | |||||
| Income taxes payable | |||||
| Deferred revenue | |||||
| Deferred government grant | |||||
| Other current and non-current liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing activities: | |||||
| Additions to property, plant and equipment | |||||
| Purchases of short-term investments | |||||
| Proceeds from sales of short-term investments | |||||
| Proceeds from maturities of short-term investments | |||||
| Investment in equity method investee | |||||
| Proceeds from return of investment in equity method investee | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Proceeds from government awards used for construction | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities: | |||||
| Proceeds from issuance of long-term debt | |||||
| Proceeds from issuance of common stock | |||||
| Proceeds from issuance of Series A preferred stock | |||||
| Proceeds from issuance of warrant | |||||
| Payment of debt issuance costs | |||||
| Payments to retire long-term debt | |||||
| Payment of equity issuance costs | |||||
| Purchase of capped call options | |||||
| Principal payments on debt obligations | |||||
| Tax withholding on stock-based awards | |||||
| Other | |||||
| Net cash provided by (used in) financing activities | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash beginning balance | |||||
| Cash, cash equivalents and restricted cash ending balance | |||||
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | |||||
| Cash and cash equivalents | |||||
| Restricted cash, current | |||||
| Restricted cash, non-current | |||||
Loading...